BLMHF logo

Bloom Health Partners Inc. (BLMHF) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

$'dan işlem gören Bloom Health Partners Inc. (BLMHF), 0 değerindeki bir Healthcare şirketidir. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 51/100 puan alıyor.

Son analiz: 17 Mar 2026
51/100 AI Puanı

Bloom Health Partners Inc. (BLMHF) Sağlık ve Boru Hattı Genel Bakışı

CEORosemary Elliston
MerkezVancouver, CA
Halka Arz Yılı2021
SektörHealthcare

Bloom Health Partners Inc., operating as Maitri Health Technologies Corp., is a healthcare supply platform providing personal protective equipment and testing solutions internationally. With a focus on face masks, sanitizers, and PCR test kits, the company serves diverse markets, though it currently navigates challenges reflected in its negative P/E ratio.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 17 Mar 2026

Yatırım Tezi

Bloom Health Partners Inc. presents a speculative investment opportunity within the healthcare supply sector. The company's gross margin of 78.4% indicates strong potential profitability on sales, but its negative P/E ratio of -2.49 and negative profit margin of -11.0% suggest underlying financial challenges. Growth catalysts include expanding its testing solutions and PPE offerings to new markets. The company's low beta of 0.31 indicates lower volatility compared to the broader market. However, investors should carefully consider the risks associated with OTC-listed companies and the company's current financial performance before investing. The company's ability to achieve sustainable profitability will be a critical factor in its long-term success.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market Cap of $0.01B indicates a micro-cap company with potential for high growth but also higher risk.
  • Gross Margin of 78.4% suggests strong pricing power and efficient cost management in its product offerings.
  • P/E Ratio of -2.49 reflects current losses, indicating the company's earnings are negative.
  • Profit Margin of -11.0% shows that the company is currently not profitable, requiring careful monitoring of expense management.
  • Beta of 0.31 indicates lower volatility compared to the market, which may appeal to risk-averse investors.

Rakipler & Benzerleri

Güçlü Yönler

  • Diverse product portfolio (PPE and testing solutions).
  • Established presence in Canada and international markets.
  • Strong gross margin (78.4%).
  • Low beta (0.31) indicating lower volatility.

Zayıflıklar

  • Negative P/E ratio (-2.49) indicating current losses.
  • Negative profit margin (-11.0%).
  • Limited brand recognition compared to larger competitors.
  • Dependence on market demand for PPE and testing solutions.

Katalizörler

  • Ongoing: Expansion of product offerings to include new testing solutions.
  • Ongoing: Strategic partnerships with healthcare providers and government agencies.
  • Upcoming: Potential government contracts for PPE and testing solutions.
  • Ongoing: Geographic expansion into new markets.
  • Ongoing: Development of innovative healthcare products and services.

Riskler

  • Potential: Intense competition from established players in the healthcare industry.
  • Potential: Fluctuations in market demand for PPE and testing solutions.
  • Potential: Evolving regulatory requirements.
  • Potential: Disruptions in supply chain.
  • Ongoing: Negative P/E ratio and profit margin indicating financial challenges.

Büyüme Fırsatları

  • Expansion of Testing Solutions: Bloom Health Partners Inc. can expand its range of testing solutions beyond PCR test kits to include rapid antigen tests and other diagnostic tools. The global market for molecular diagnostics is projected to reach $14 billion by 2027, presenting a significant opportunity for growth. By offering a comprehensive suite of testing solutions, the company can cater to a wider range of customer needs and increase its market share. Timeline: Within the next 1-2 years.
  • Geographic Expansion: Bloom Health Partners Inc. can expand its operations into new geographic markets, particularly in regions with high demand for PPE and testing solutions. Emerging markets in Asia and Latin America offer significant growth potential. By establishing partnerships with local distributors and healthcare providers, the company can gain access to new customers and increase its revenue streams. Timeline: Within the next 2-3 years.
  • Strategic Partnerships: Bloom Health Partners Inc. can form strategic partnerships with healthcare providers, government agencies, and other organizations to expand its reach and market penetration. Collaborating with established players in the healthcare industry can provide access to new distribution channels and customer networks. These partnerships can also facilitate the development of new products and services tailored to specific market needs. Timeline: Ongoing.
  • Product Innovation: Bloom Health Partners Inc. can invest in research and development to create innovative products and services that address emerging healthcare needs. Developing new testing technologies, advanced PPE, and other healthcare solutions can differentiate the company from its competitors and attract new customers. Focusing on innovation can also help the company stay ahead of evolving regulatory requirements and market trends. Timeline: Ongoing.
  • Government Contracts: Bloom Health Partners Inc. can actively pursue government contracts to supply PPE and testing solutions to public sector organizations. Governments around the world are investing heavily in healthcare infrastructure and pandemic preparedness, creating significant opportunities for companies that can provide reliable and cost-effective solutions. Securing government contracts can provide a stable revenue stream and enhance the company's reputation. Timeline: Ongoing.

Fırsatlar

  • Expansion into new geographic markets.
  • Development of innovative products and services.
  • Strategic partnerships with healthcare providers and government agencies.
  • Increased demand for testing solutions due to ongoing health concerns.

Tehditler

  • Intense competition from established players.
  • Fluctuations in market demand for PPE and testing solutions.
  • Evolving regulatory requirements.
  • Potential disruptions in supply chain.

Rekabet Avantajları

  • Established relationships with suppliers and distributors.
  • Focus on quality and reliability of products.
  • Ability to adapt to evolving market demands and regulatory requirements.
  • Diverse product portfolio including PPE and testing solutions.

BLMHF Hakkında

Maitri Health Technologies Corp., now operating as Bloom Health Partners Inc., was established to address the growing demand for healthcare supplies and testing solutions. The company focuses on providing personal protective equipment (PPE) and testing technologies to various sectors, including healthcare, government, and private enterprises. Bloom Health Partners Inc. offers a range of products, including face masks, face shields, anti-viral cleaning solutions, sanitizers, disinfectants, and PCR test kits. These products are designed to help organizations and individuals mitigate health risks and maintain safe environments. The company operates primarily in Canada and internationally, catering to the needs of diverse markets. Bloom Health Partners Inc. has positioned itself as a key supplier of essential healthcare products, particularly in response to global health crises. The company's focus on quality and reliability has enabled it to establish a presence in a competitive market. Despite its market presence, Bloom Health Partners Inc. faces challenges, as reflected in its negative price-to-earnings ratio. The company continues to adapt its offerings to meet evolving market demands and regulatory requirements.

Ne Yaparlar

  • Provides personal protective equipment (PPE) such as face masks and face shields.
  • Offers anti-viral cleaning solutions, sanitizers, and disinfectants.
  • Supplies PCR test kits for diagnostic testing.
  • Operates as a healthcare supply platform.
  • Serves markets in Canada and internationally.
  • Provides testing and technology solutions.

İş Modeli

  • Sells personal protective equipment (PPE) to healthcare providers, government agencies, and private enterprises.
  • Offers testing solutions, including PCR test kits, to organizations and individuals.
  • Generates revenue through direct sales and distribution agreements.
  • Focuses on providing essential healthcare products and services to meet market demand.

Sektör Bağlamı

Bloom Health Partners Inc. operates within the medical instruments and supplies industry, a sector driven by healthcare needs, technological advancements, and regulatory requirements. The global market for medical devices is projected to reach substantial growth in the coming years, fueled by an aging population and increased healthcare spending. Competition is intense, with established players and emerging companies vying for market share. Bloom Health Partners Inc. focuses on PPE and testing solutions, positioning it within a niche segment of the broader healthcare market. The company's success depends on its ability to innovate, maintain quality standards, and navigate the evolving regulatory landscape.

Kilit Müşteriler

  • Healthcare providers (hospitals, clinics, and medical practices).
  • Government agencies (public health departments and emergency response teams).
  • Private enterprises (businesses and organizations).
  • Individuals seeking personal protective equipment and testing solutions.
AI Güveni: 71% Güncellendi: 17 Mar 2026

Finansallar

Grafik & Bilgi

Bloom Health Partners Inc. (BLMHF) hisse senedi fiyatı: Price data unavailable

Son Haberler

BLMHF için son haber bulunmamaktadır.

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

BLMHF için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

BLMHF için Wall Street fiyat hedefi analizi.

MoonshotScore

51/100

Bu puan ne anlama geliyor?

MoonshotScore, BLMHF'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Rosemary Elliston

CEO

Rosemary Elliston is the Chief Executive Officer of Bloom Health Partners Inc. Her background includes extensive experience in healthcare management and strategic leadership. She has held various leadership positions in healthcare organizations, focusing on operational efficiency and market expansion. Elliston's expertise spans across healthcare supply chain management, regulatory compliance, and business development. Her experience positions her to lead Bloom Health Partners Inc. through its growth phases.

Sicil: Under Rosemary Elliston's leadership, Bloom Health Partners Inc. has focused on expanding its product offerings and market reach. Key initiatives include strengthening relationships with suppliers and distributors, enhancing the company's testing solutions, and pursuing strategic partnerships. Elliston's strategic decisions have aimed to improve the company's financial performance and market position, despite the challenges in the current economic environment.

BLMHF OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that Bloom Health Partners Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk due to the potential for less transparency and liquidity compared to listed exchanges.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: As an OTC-listed stock, BLMHF may experience lower trading volumes and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more difficult for investors to buy or sell shares quickly and at desired prices. Investors should be aware of the potential for price volatility and limited liquidity when trading BLMHF.
OTC Risk Faktörleri:
  • Limited financial disclosure and transparency.
  • Lower trading volumes and liquidity.
  • Potential for price volatility.
  • Higher risk of fraud or manipulation compared to listed exchanges.
  • Limited regulatory oversight.
Durum Tespiti Kontrol Listesi:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's risk factors and potential liabilities.
  • Check for any legal or regulatory issues.
  • Monitor trading volume and price volatility.
  • Consult with a financial advisor before investing.
Meşruiyet Sinyalleri:
  • Company operates in a regulated industry (healthcare).
  • Company has a functional website and contact information.
  • Company has a CEO and management team.
  • Company offers tangible products and services (PPE and testing solutions).
  • Company has been in operation for several years.

Bloom Health Partners Inc. Hissesi: Cevaplanan Temel Sorular

BLMHF için değerlendirilmesi gereken temel faktörler nelerdir?

Bloom Health Partners Inc. (BLMHF) şu anda yapay zeka skoru 51/100, orta puanı gösteriyor. Temel güçlü yan: Diverse product portfolio (PPE and testing solutions).. İzlenmesi gereken birincil risk: Potential: Intense competition from established players in the healthcare industry.. Bu bir finansal tavsiye değildir.

BLMHF MoonshotScore'u nedir?

BLMHF şu anda MoonshotScore'da 51/100 (Derece C) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

BLMHF verileri ne sıklıkla güncellenir?

BLMHF fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler BLMHF hakkında ne diyor?

BLMHF için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

BLMHF'a yatırım yapmanın riskleri nelerdir?

BLMHF için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Intense competition from established players in the healthcare industry.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

BLMHF'ın P/E oranı nedir?

BLMHF için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için BLMHF'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

BLMHF aşırı değerli mi, yoksa düşük değerli mi?

Bloom Health Partners Inc. (BLMHF)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

BLMHF'ın temettü verimi nedir?

Bloom Health Partners Inc. (BLMHF) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Financial data is based on the most recent available information.
  • OTC market data may be limited and subject to change.
  • AI analysis is pending and may provide additional insights.
Veri Kaynakları

Popüler Hisseler